Blockchain Registration Transaction Record

Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth

Helix BioPharma Corp. announces the appointment of Veronika Kandziora as COO and Jessica Kourniaktis as Director of Communications to drive growth and advance the fight against hard-to-treat cancers. Learn more about the strategic moves and key players at Helix.

This news highlights the strategic moves made by Helix BioPharma Corp. to strengthen its leadership team and enhance communication efforts. The appointments of Kandziora and Kourniaktis signify a pivotal stage in Helix's development, signaling a determined focus on achieving its goals in the fight against hard-to-treat cancers. The expertise brought by these key players will play a significant role in shaping the future of oncology treatments.